PBAC meeting July 2020

At the upcoming Pharmaceutical Benefits Advisory Committee (PBAC) meeting in July, there will be two submissions made relating to drugs that are used to treat myeloma, namely daratumumab and carfilzom...

BLOOD

A team from Myeloma Australia had the opportunity to attend ‘Blood2018’ (formerly HAA) the largest haematology conference in Australia in Brisbane at the end of October. With our team of ten Myeloma S...

Sydney City2Surf Running Blog

Running blog “Let the training commence” “White rabbits” “pinch, punch first day of the month” also day one of my training for “Team Myeloma” City to Surf 2018! I have entered this event several times...

PBAC consumer comments open for denosumab

Myeloma Australia is committed to keeping the Australian myeloma community informed about any new treatment submissions to be considered by the Pharmaceutical Benefits Advisory Committee (PBAC). The P...

Fundraising update

There is much activity at this time in the fundraising space of Myeloma Australia. Our first major fundraising event for the year was our flagship Business of Winning Luncheon at the MCG. This was a g...

COVID-19 UPDATE: As per the Victorian Premier’s announcement, Victoria will be in an extended lockdown until further notice. Due to this, our Head Office in Melbourne will be closed and will reopen pending the decisions of the Victorian State Government.
During this time, all staff will be working from home. To contact Myeloma Australia team members, please use their direct contact details on our Contact page. If you need to contact our myeloma support nurses, please do so via email to nurses@myeloma.org.au or phone call to our toll free myeloma telephone support line on 1800 693 566. We are currently reviewing our events calendar and will update you as soon as possible. Please continue to visit our events calendar and socials for updates.

X